AI is becoming more capable, but its value still depends on the data, questions and decisions behind it. Where is it ...

News: DXC’s new Bengaluru centre reflects India’s expanding role in enterprise modernisation as AI, legacy systems and ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

When checking that solutions to certain problems are correct, it turns out, you can’t get around the inherent complexity of ...